82

China Health Group IncHKG 8225 Stock Report

Last reporting period 31 Dec, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.013

Micro

Exchange

XHKG - Hong Kong Exchange

8225.HK Stock Analysis

82

Uncovered

China Health Group Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

12/100

Low score

Market cap $B

0.013

Dividend yield

Shares outstanding

995.35 B

China Health Group, Inc. is an investment holding company, which provides drug discovery and development services. The company is headquartered in Beijing, Beijing and currently employs 50 full-time employees. The company went IPO on 2003-07-10. The firm provides hospital clinical research and product promotion services, hospital management services, mobile telemedicine services, special expertise therapy services and rehabilitation and medical tours services. Its clinical research services include Phase I clinical and bioequivalence studies, Phase IV post-marketing clinical study, data management and medical statistics and medical administration-related services, among others. Its hospital management services include Internet healthcare services and drug delivery services, such as Chinese best doctor and My doctor 999, among others.

View Section: Eyestock Rating